Crinetics Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Crinetics Pharmaceuticals's estimated annual revenue is currently $2.4M per year.
- Crinetics Pharmaceuticals received $63.5M in venture funding in March 2018.
- Crinetics Pharmaceuticals's estimated revenue per employee is $9,830
- Crinetics Pharmaceuticals's total funding is $446M.
- Crinetics Pharmaceuticals's current valuation is $1.1B. (January 2022)
Employee Data
- Crinetics Pharmaceuticals has 247 Employees.
- Crinetics Pharmaceuticals grew their employee count by 36% last year.
Crinetics Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | $11.5M | 74 | -12% | N/A | N/A |
#7 | $0.4M | 275 | 10% | $236.7M | N/A |
#8 | $4M | 51 | -74% | $160M | N/A |
#9 | $2.5M | 16 | 33% | N/A | N/A |
#10 | $3.3M | 21 | -12% | N/A | N/A |
What Is Crinetics Pharmaceuticals?
Neuropeptide Receptor Targeted Therapeutics for the Treatment of Endocrine Diseases and Cancers. We are driven by a passion for drug-hunting and tempered by a post-recession startup culture. Our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$446M
Total Funding
247
Number of Employees
$2.4M
Revenue (est)
36%
Employee Growth %
$1.1B
Valuation
N/A
Accelerator
Crinetics Pharmaceuticals News
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Forecasted to ... Defense World
Crinetics Pharmaceuticals Announces Pricing of Underwritten ... GlobeNewswire
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year ... GlobeNewswire
Photo Courtesy of Crinetics San Diego-based Crinetics Pharmaceuticals focuses on discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 m ...
SAN DIEGO - October 25, 2021 - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that is has closed it ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.2M | 247 | -49% | $264.4M |
#2 | $55.1M | 249 | 41% | N/A |
#3 | $49.5M | 250 | N/A | N/A |
#4 | $38.9M | 251 | 4% | N/A |
#5 | $33.1M | 251 | 4% | N/A |
Crinetics Pharmaceuticals Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-11-03 | $40.0M | A | 5AM Ventures | Article |
| 2018-03-15 | $63.5M | B | Perceptive Advisors | Article |